Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 3 of 3 citing Picha: Protein Engineering Strategies for Sustained Glucagon-Like Peptide-1 Receptor–Dependent.... (0.06 sec) 

Development of mammalian production cell lines expressing CNTO736, a glucagon like …


H Dorai, JF Nemeth, E Cammaart, Y Wang, QM … - Biotechnology and Bioengineering, 2009 - interscience.wiley.com
In an attempt to develop a high producing mammalian cell line expressing
CNTO736, a Glucagon like peptide-1-antibody fusion protein (also known as a
Glucagon like peptide-1 MIMETIBODY TM ), we have noted that the N-terminal ...
Related articles - All 2 versions

CNTO736, a Novel Glucagon-Like Peptide-1 Receptor Agonist, Ameliorates Insulin …


ET Parlevliet, JP Elst, EPM Corssmit, K Picha, … - Journal of Pharmacology and Experimental …, 2009 - ASPET
CNTO736 is a glucagon-like peptide (GLP) 1 receptor agonist that incorporates a
GLP-1 peptide analog linked to the Mimetibody platform. We evaluate the
potential of acute and chronic CNTO736 treatment on insulin sensitivity and ...
Related articles - All 3 versions

[PDF] 胰高血糖素样肽-1 受体靶向药物研究进展


李彩娜, 申竹芳 - newdrug.cn
[Abstract]: Glucagon-like peptide-1(GLP-1) belongs to the incretin family. It is
a 30-amino acid peptide secreted from the intestinal L cell in response to food
ingestion. It can bind to the GLP-1 receptor to exert a variety of ...
Related articles - View as HTML - All 2 versions


 


Go to Google Home - About Google - About Google Scholar

©2009 Google